These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10640522)

  • 21. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.
    Nishimura T; Amano N; Kubo Y; Ono M; Kato Y; Fujita H; Kimura Y; Tsuji A
    Drug Metab Dispos; 2007 Aug; 35(8):1275-84. PubMed ID: 17470527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug-Drug Interactions.
    Pang KS; Peng HB; Noh K
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32244748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption of benzoic acid in segmental regions of the vascularly perfused rat small intestine preparation.
    Cong D; Fong AK; Lee R; Pang KS
    Drug Metab Dispos; 2001 Dec; 29(12):1539-47. PubMed ID: 11717172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis.
    Tam D; Sun H; Pang KS
    Drug Metab Dispos; 2003 Oct; 31(10):1214-26. PubMed ID: 12975330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.
    Pang KS
    Drug Metab Dispos; 1995 Feb; 23(2):166-77. PubMed ID: 7736907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
    Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of etretinate and its metabolites in the dog.
    Thongnopnua P; Massarella JW; Zimmerman CL
    Drug Metab Dispos; 1989; 17(5):473-80. PubMed ID: 2573489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of diffusional barriers on presystemic gut elimination.
    Gwilt PR; Comer S; Chaturvedi PR; Waters DH
    Drug Metab Dispos; 1988; 16(4):521-6. PubMed ID: 2903017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral absorption and oxidative metabolism of atrazine in rats evaluated by physiological modeling approaches.
    McMullin TS; Hanneman WH; Cranmer BK; Tessari JD; Andersen ME
    Toxicology; 2007 Oct; 240(1-2):1-14. PubMed ID: 17767989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of physiologically based pharmacokinetic models to evaluate the impact of intestinal glucuronide hydrolysis on the pharmacokinetics of aglycone.
    Wu B
    J Pharm Sci; 2012 Mar; 101(3):1281-301. PubMed ID: 22109716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism.
    Fan J; Chen S; Chow EC; Pang KS
    Curr Drug Metab; 2010 Nov; 11(9):743-61. PubMed ID: 21189137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Route-dependent metabolism of morphine in the vascularly perfused rat small intestine preparation.
    Doherty MM; Pang KS
    Pharm Res; 2000 Mar; 17(3):291-8. PubMed ID: 10801217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug.
    Nassar T; Rom A; Nyska A; Benita S
    J Control Release; 2009 Jan; 133(1):77-84. PubMed ID: 18822327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats.
    Crowe A; Bruelisauer A; Duerr L; Guntz P; Lemaire M
    Drug Metab Dispos; 1999 May; 27(5):627-32. PubMed ID: 10220493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.
    Schwarz UI; Hanso H; Oertel R; Miehlke S; Kuhlisch E; Glaeser H; Hitzl M; Dresser GK; Kim RB; Kirch W
    Clin Pharmacol Ther; 2007 May; 81(5):669-78. PubMed ID: 17392718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.